ロード中...
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC
BACKGROUND: Adjuvant chemotherapy improves survival in patients with completely resected stage II and III NSCLC. However, its role in patients with stage IB NSCLC disease remains unclear. We evaluated the role of adjuvant chemotherapy in a large data set of patients with completely resected T2N0M0 N...
保存先:
| 出版年: | J Thorac Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5141602/ https://ncbi.nlm.nih.gov/pubmed/27287414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.05.022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|